Jeroen Eikenboom
A5017437441- Platelet Disorders and Treatments
- Blood groups and transfusion
- Hemophilia Treatment and Research
- Venous Thromboembolism Diagnosis and Management
- Heparin-Induced Thrombocytopenia and Thrombosis
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Blood Coagulation and Thrombosis Mechanisms
- Antiplatelet Therapy and Cardiovascular Diseases
- Blood disorders and treatments
- Complement system in diseases
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Maternal and fetal healthcare
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Atrial Fibrillation Management and Outcomes
- Blood properties and coagulation
- Systemic Lupus Erythematosus Research
- Chronic Myeloid Leukemia Treatments
- Blood transfusion and management
- COVID-19 Clinical Research Studies
- Adolescent and Pediatric Healthcare
- Trauma and Emergency Care Studies
- Cardiac Arrhythmias and Treatments
- Cellular transport and secretion
- Hemoglobinopathies and Related Disorders
- Autoimmune Bullous Skin Diseases
Leiden University Medical Center
2016-2025
Leiden University
2011-2025
Sanquin
2006-2023
University of Amsterdam
2013-2023
Loyola University Medical Center
2016-2023
Public Health Service of Amsterdam
2023
Amsterdam University Medical Centers
2023
Emma Kinderziekenhuis
2023
Erasmus MC - Sophia Children’s Hospital
2021
Erasmus MC
2015-2021
von Willebrand disease (VWD) is the most common inherited bleeding disorder known in humans. Accurate and timely diagnosis presents numerous challenges.These evidence-based guidelines of American Society Hematology (ASH), International on Thrombosis Haemostasis (ISTH), National Hemophilia Foundation (NHF), World Federation (WFH) are intended to support patients, clinicians, other health care professionals their decisions about VWD diagnosis.ASH, ISTH, NHF, WFH established a multidisciplinary...
Background: A positive family history of venous thrombosis may reflect the presence genetic risk factors.Once a factor has been identified, it is not known whether additional value in predicting an individual's risk.We studied contribution to relation factors.Methods: In Multiple Environmental and Genetic Assessment factors for thrombosis, population-based case-control study, we collected blood samples information about environmental triggers from 1605 patients with first 2159 control...
Factor VIII activity (factor VIII:C) levels > or =150 IU/dl are associated with a 5- to 6-fold increased risk of venous thrombosis compared <100 IU/dl, and fibrinogen =5.0 g/l increase the 4-fold. These high present in 25% resp. 3% patients first episode thrombosis. findings were based on measurements after thrombotic event, so factor may have been influenced by acute phase reactions ongoing inflammatory responses. In study we measured plasma C-reactive protein (CRP) as sensitive marker an...
Background Treatment of patients with hemophilia has advanced over the past decades, but it is unknown whether this resulted in a normal life expectancy Netherlands. Objective This observational cohort study aimed to assess all-cause and cause-specific mortality Netherlands between 2001 2018 compare previous survival assessments from 1973 onward. Patients/methods All 1066 who participated nationwide survey were followed until July 2018. Results Information on 1031 individuals (97%) was...